Aged Garlic Extract: A New Compound to Shield Aging Muscles

Research published in Cell Metabolism (2026) reveals that a specific metabolite found in aged garlic extract, S-1-propenyl-L-cysteine (S1PC) , acts as a molecular “linker” that recharges the body’s systemic energy regulation. Unlike generic supplements, S1PC triggers a precise signaling cascade starting in the fat tissue that ultimately boosts muscle strength and reduces frailty by communicating directly with the brain.

The “Big Idea” centers on eNAMPT , a critical enzyme responsible for the biosynthesis of nicotinamide adenine dinucleotide (NAD) , a coenzyme essential for cellular energy and longevity. As we age, circulating eNAMPT levels decline, leading to reduced NAD in the hypothalamus—the brain’s command center for metabolic tone. This study demonstrates that S1PC binds to a protein called LKB1 in white adipose tissue, enhancing its ability to form a complex that activates SIRT1 , a well-known longevity protein. This activation forces fat cells to secrete eNAMPT-laden extracellular vesicles into the bloodstream.

The impact of this relay is systemic. In aged mice, this surge in eNAMPT specifically targeted the hypothalamus, which in turn increased sympathetic nervous system signaling to the skeletal muscles. The result was a significant increase in muscle force and a restoration of body temperature to youthful levels, effectively lowering the mice’s “frailty index”.

Crucially, the researchers translated these findings to humans. In a double-blind, placebo-controlled trial, S1PC administration increased circulating eNAMPT levels in middle-aged individuals, though this effect was dependent on having a healthy amount of body fat. This suggests that the “fat-to-brain-to-muscle” pathway is a conserved mechanism that could be harnessed to combat sarcopenia and age-related decline in the elderly.


Actionable Insights

  • Aged Garlic Extract (AGE) vs. Raw Garlic: The bioactive compound S1PC is relatively abundant in aged garlic extract but not raw garlic. Consumers seeking this specific benefit should prioritize AGE supplements.

  • Adipose Tissue as a Longevity Organ: Systemic NAD health is partially dependent on white adipose tissue (WAT). In the human trial, individuals with a BMI below 18.5 (underweight) did not see the same eNAMPT boost as those with healthy fat mass. Maintaining healthy adiposity is a prerequisite for S1PC’s efficacy.

  • Synergy with NAD Boosters: The study found that combining S1PC with Nicotinamide Mononucleotide (NMN) significantly enhanced circulating eNAMPT levels compared to either compound alone. Biohackers already using NMN or NR may find S1PC a potent “force multiplier” for systemic NAD availability. [Confidence: Medium]

  • Targeting Frailty: S1PC specifically improved high-frequency muscle force and reduced frailty scores in mice. This indicates potential utility for aging populations experiencing muscle weakness (sarcopenia) rather than those seeking acute athletic performance gains. [Confidence: Medium]


Context

Related Reading:

The Translational Protocol

  • Human Equivalent Dose (HED): The mouse dose utilized for healthspan improvements was 5 mg/kg. Using Body Surface Area (BSA) normalization (FDA/ICH guidance):

    • Formula: Human Dose (mg/kg) = Animal Dose (mg/kg) × (Animal Km / Human Km)
    • Math: 5 mg/kg × (3 / 37) = 0.405 mg/kg
    • Total Daily Dose (70 kg Adult): ~28.35 mg.
    • Clinical Alignment: The human trial in this study used 25 mg per dose, which aligns with the calculated HED for a 60–70 kg individual.
  • Pharmacokinetics (PK/PD):

    • Absorption: Rapid. In humans, plasma concentrations increase quickly, reaching approximately 4.14 μM within 120 minutes of oral administration.
    • Distribution: In mice, S1PC distributes to the brain, gastrocnemius muscle, and white adipose tissue (WAT) within 15 minutes.
    • Bioavailability/Half-life: Plasma levels in mice decline rapidly after the 15-minute peak. Human half-life is not explicitly detailed beyond the 120-minute observation window.
  • Safety & Toxicity:

    • Animal Safety: No toxicity was detected in mice after oral administration of 1,000 mg/kg for 2 weeks.
    • NOAEL/LD50: Formal NOAEL (No Observed Adverse Effect Level) and LD50 (Lethal Dose) values were not established, though the 1,000 mg/kg mouse dose suggests a high safety margin (approx. 200x the therapeutic dose).
    • Clinical Safety: Single doses of 25 mg in humans (n=40) were well-tolerated with no reported adverse effects.
    • Organ Signals: No adverse liver or kidney signals were reported; notably, S1PC did not stimulate lipolysis (no increase in free fatty acids) in humans.

Biomarker Verification

Target engagement can be verified via the following downstream changes:

  1. Primary Engagement: Increase in circulating eNAMPT-EVs (Extracellular Vesicle-contained extracellular nicotinamide phosphoribosyltransferase).

  2. Adipose Engagement: Increased phosphorylation of SIRT1 (Ser615) in white adipose tissue (requires biopsy).

  3. Physiological Signature: Restoration of rectal/core body temperature and increased grip strength or muscle force frequency.

Feasibility & ROI

  • Sourcing: Currently not commercially available as a standalone pure compound. The researchers produced a specific 17% S1PC-enriched garlic powder for the study. While Aged Garlic Extract (AGE) contains S1PC, standard retail concentrations are significantly lower than the levels required for the 25 mg dose.

  • Cost vs. Effect:

    • Estimated Cost: High, if attempting to reach 25 mg S1PC via standard AGE (likely requiring excessive volume).
    • Marginal Gain: In mice, the ROI is high for frailty reduction and skeletal muscle force. In humans, ROI for long-term muscle function remains speculative pending multi-dose trials.

Based on the study by Suzuki et al. (2026), the following effect sizes were observed for the garlic-derived metabolite S-1-propenyl-L-cysteine (S1PC) across molecular, physiological, and clinical metrics.

Effect Sizes in Mice

The study utilized both acute single-dose (5 mg/kg) and long-term dietary administration (8 months) in aged mice.

Molecular & Cellular Metrics:

  • LKB1 Complex Formation: In differentiated adipocytes, S1PC increased the amounts of co-immunoprecipitated STRAD by 62% and MO25 by 77% compared to controls.

  • SIRT1 Activation: S1PC introduction led to an approximately 30% increase in the serine phosphorylation of SIRT1 at the 30-minute time point.

  • Hypothalamic NAD+: In young mice, hypothalamic NAD+ levels increased from approximately 425 to 480 pmol/mg (~13% increase) within 30 minutes of oral administration.

Physiological & Functional Metrics (Aged Mice):

  • Frailty Index (FI) Score: Long-term treatment significantly reduced the FI score from approximately 0.25 to 0.20 (a ~20% reduction in accumulated deficits).

  • Skeletal Muscle Force: At high-frequency electrical stimulation (200 Hz), muscle force in aged mice increased from approximately 310 mN to 360 mN (a ~16% improvement).

  • Body Temperature: Rectal temperature was restored from a senescent level of approximately 36.5°C to a more youthful level of 37.3°C.


Effect Sizes in Humans

The human clinical trial evaluated the acute effects of a single 25 mg dose of S1PC in subjects aged 20–49.

  • Circulating eNAMPT Levels: In the subgroup of healthy middle-aged individuals (age ≥ 40, BMI ≥ 18.5), S1PC increased relative plasma eNAMPT levels by approximately 1.3-fold (30% increase) compared to baseline at the 120-minute mark.

  • S1PC Plasma Concentration: Reached an average peak concentration of 4.14 μM at 120 minutes post-ingestion.

  • Statistical Correlation: The increase in circulating eNAMPT at 120 minutes showed a statistically significant correlation with Body Mass Index (R^2 = 0.2994, p = 0.0153).

Summary Table of Major Benefits

Metric Species Effect Size (Approx.)
LKB1 Complex (STRAD) Mouse (Cell)
+62%
LKB1 Complex (MO25) Mouse (Cell)
+77%
Frailty Index Reduction Mouse (Aged)
-20%
Muscle Force (200 Hz) Mouse (Aged)
+16%
Circulating eNAMPT Human (Age ≥ 40)
+30%

Puchasing Options:

As of May 7, 2026, the market for standardized aged garlic extract (AGE) is primarily dominated by the Kyolic® brand (Wakunaga of America), which pioneered the proprietary 20-month cold-aging process. While clinical research released today identifies S1PC (S-1-propenyl-L-cysteine) as a critical bioactive metabolite for muscle health and longevity, most commercial products continue to use SAC (S-allyl cysteine) as the primary standardization marker.

The following table identifies the lowest-cost sources for aged garlic extract capsules available in the USA, prioritizing high-volume standardized formulas.

Top 10 Lowest-Cost Standardized Aged Garlic Extract Capsules (USA)

Rank Product/Brand Name Vendor Total Weight (Original & Grams) Total Price (USD) Cost Per 25mg (AGE)
1 Kyolic Formula 100 Original, 300 Caps iHerb 300 caps (300mg/cap) = 90g $26.18 $0.0073
2 Kyolic Formula 104 Cholesterol, 300 Caps iHerb 300 caps (300mg/cap) = 90g $32.66 $0.0091
3 Kyolic Reserve Formula 200, 120 Caps iHerb 120 caps (600mg/cap) = 72g $27.56 $0.0096
4 Micro Ingredients Odorless AGE, 300 Softgels iHerb 300 caps (250mg/cap) = 75g $26.99 $0.0090
5 Kyolic Formula 100 Original, 300 Caps Target 300 caps (300mg/cap) = 90g $34.99 $0.0097
6 Kyolic Formula 102 Cleanse, 200 Veggie Caps iHerb 200 caps (300mg/cap) = 60g $26.09 $0.0109
7 Kyolic Formula 107 Phytosterols, 240 Caps Walmart 240 caps (300mg/cap) = 72g $44.17 $0.0153
8 Kyolic Formula 109 BP Health, 240 Caps iHerb 240 caps (200mg/cap) = 48g $60.71 $0.0316
9 Kyolic Formula 103 Immune, 100 Caps Target 100 caps (220mg/cap) = 22g $16.99 $0.0193
10 NOW Odorless Garlic Extract, 100 Softgels iHerb 100 caps (25mg/cap*) = 2.5g $7.73 $0.0773

*Note: NOW Foods “Odorless Garlic” uses a 20:1 concentrate that equals roughly 500mg of raw garlic, but the extract weight itself is lower per unit than Kyolic standardized formulas.


Shipping & Availability Notes

  • iHerb: Free shipping on orders over $30.00. Orders below this threshold incur a flat rate of approximately $5.00–$7.00.
  • Target: Free shipping on orders over $35.00 or free for Target RedCard holders.
  • Walmart: Free shipping on orders over $35.00; otherwise, shipping is approximately $6.99.
  • S1PC Identification: While research confirms S1PC is a major constituent of all Kyolic AGE products, standard retail labels do not yet list S1PC milligram amounts as of May 2026. Kyolic remains the only brand explicitly referenced in the S1PC studies as providing the necessary metabolite profile.
1 Like